Blog y noticias

Comunicado de prensa | 09.05.2026

Echosens Appoints Romain Baujard as Group Chief Executive Officer

Libro blanco | 09.05.2026

New White Paper – Vibration-Controlled Transient Elastography Explained

Artículo | 09.05.2026

Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)

Artículo | 09.05.2026

A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH

Comunicado de prensa | 09.05.2026

Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH

Comunicado de prensa | 09.05.2026

Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics

Comunicado de prensa | 09.05.2026

Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care

Artículo | 09.05.2026

A call for doubling the diagnostic rate of at-risk MASH

Webinar | 09.05.2026

Mejorando mi práctica clínica usando la elastografía esplénica

Congress | 09.05.2026

Echosens is at EASL

Artículo | 09.05.2026

New publication on our new technology Guided VCTE™

Comunicado de prensa | 09.05.2026

Echosens lanza su plataforma de gestión de la salud hepática (LHM) a nivel mundial

Comunicado de prensa | 09.05.2026

Meet the Inaugural Echosens Liver Health Super Shaper Award Recipients

Webinar | 09.05.2026

Redescubre el Club NASH : 3 episodios sobre la gestión de MASLD / MASH

Podcast | 09.05.2026

A New Era in MASH Treatment